PortfoliosLab logoPortfoliosLab logo
IOVA vs. ET
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

IOVA vs. ET - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Iovance Biotherapeutics, Inc. (IOVA) and Energy Transfer LP (ET). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

IOVA vs. ET - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IOVA
Iovance Biotherapeutics, Inc.
28.57%-63.11%-8.98%27.23%-66.53%-58.86%67.63%212.77%10.62%15.11%
ET
Energy Transfer LP
19.24%-9.37%53.87%27.87%55.74%42.96%-44.92%5.88%-17.74%-4.66%

Fundamentals

Market Cap

IOVA:

$1.43B

ET:

$70.45B

EPS

IOVA:

-$1.06

ET:

$1.37

PS Ratio

IOVA:

4.91

ET:

0.84

PB Ratio

IOVA:

2.04

ET:

1.44

Total Revenue (TTM)

IOVA:

$263.50M

ET:

$82.63B

Gross Profit (TTM)

IOVA:

$256.22M

ET:

$18.01B

EBITDA (TTM)

IOVA:

-$357.11M

ET:

$14.93B

Returns By Period

In the year-to-date period, IOVA achieves a 28.57% return, which is significantly higher than ET's 19.24% return. Over the past 10 years, IOVA has underperformed ET with an annualized return of -3.87%, while ET has yielded a comparatively higher 20.51% annualized return.


IOVA

1D
5.72%
1M
-9.07%
YTD
28.57%
6M
61.75%
1Y
5.41%
3Y*
-16.87%
5Y*
-35.81%
10Y*
-3.87%

ET

1D
-1.48%
1M
2.44%
YTD
19.24%
6M
16.88%
1Y
12.07%
3Y*
25.52%
5Y*
29.51%
10Y*
20.51%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IOVA vs. ET — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IOVA
IOVA Risk / Return Rank: 4747
Overall Rank
IOVA Sharpe Ratio Rank: 4444
Sharpe Ratio Rank
IOVA Sortino Ratio Rank: 5555
Sortino Ratio Rank
IOVA Omega Ratio Rank: 5454
Omega Ratio Rank
IOVA Calmar Ratio Rank: 4141
Calmar Ratio Rank
IOVA Martin Ratio Rank: 4141
Martin Ratio Rank

ET
ET Risk / Return Rank: 5757
Overall Rank
ET Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
ET Sortino Ratio Rank: 5252
Sortino Ratio Rank
ET Omega Ratio Rank: 5454
Omega Ratio Rank
ET Calmar Ratio Rank: 5858
Calmar Ratio Rank
ET Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IOVA vs. ET - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Iovance Biotherapeutics, Inc. (IOVA) and Energy Transfer LP (ET). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IOVAETDifference

Sharpe ratio

Return per unit of total volatility

0.05

0.51

-0.46

Sortino ratio

Return per unit of downside risk

0.95

0.86

+0.10

Omega ratio

Gain probability vs. loss probability

1.13

1.12

+0.01

Calmar ratio

Return relative to maximum drawdown

-0.03

0.65

-0.68

Martin ratio

Return relative to average drawdown

-0.04

1.82

-1.86

IOVA vs. ET - Sharpe Ratio Comparison

The current IOVA Sharpe Ratio is 0.05, which is lower than the ET Sharpe Ratio of 0.51. The chart below compares the historical Sharpe Ratios of IOVA and ET, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


IOVAETDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.05

0.51

-0.46

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.40

1.17

-1.56

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.05

0.56

-0.61

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.14

0.36

-0.49

Correlation

The correlation between IOVA and ET is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

IOVA vs. ET - Dividend Comparison

IOVA has not paid dividends to shareholders, while ET's dividend yield for the trailing twelve months is around 6.87%.


TTM20252024202320222021202020192018201720162015
IOVA
Iovance Biotherapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ET
Energy Transfer LP
6.87%7.97%6.51%8.95%7.33%7.41%17.27%9.51%9.24%6.66%5.90%7.42%

Drawdowns

IOVA vs. ET - Drawdown Comparison

The maximum IOVA drawdown since its inception was -99.37%, which is greater than ET's maximum drawdown of -87.81%. Use the drawdown chart below to compare losses from any high point for IOVA and ET.


Loading graphics...

Drawdown Indicators


IOVAETDifference

Max Drawdown

Largest peak-to-trough decline

-99.37%

-87.81%

-11.56%

Max Drawdown (1Y)

Largest decline over 1 year

-54.41%

-17.33%

-37.08%

Max Drawdown (5Y)

Largest decline over 5 years

-94.98%

-25.82%

-69.16%

Max Drawdown (10Y)

Largest decline over 10 years

-96.84%

-72.82%

-24.02%

Current Drawdown

Current decline from peak

-97.79%

-1.88%

-95.91%

Average Drawdown

Average peak-to-trough decline

-84.00%

-25.95%

-58.05%

Ulcer Index

Depth and duration of drawdowns from previous peaks

37.72%

6.24%

+31.48%

Volatility

IOVA vs. ET - Volatility Comparison

Iovance Biotherapeutics, Inc. (IOVA) has a higher volatility of 30.93% compared to Energy Transfer LP (ET) at 4.96%. This indicates that IOVA's price experiences larger fluctuations and is considered to be riskier than ET based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


IOVAETDifference

Volatility (1M)

Calculated over the trailing 1-month period

30.93%

4.96%

+25.97%

Volatility (6M)

Calculated over the trailing 6-month period

65.62%

11.68%

+53.94%

Volatility (1Y)

Calculated over the trailing 1-year period

112.34%

23.80%

+88.54%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

90.77%

25.48%

+65.29%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

81.92%

36.63%

+45.29%

Financials

IOVA vs. ET - Financials Comparison

This section allows you to compare key financial metrics between Iovance Biotherapeutics, Inc. and Energy Transfer LP. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B25.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
86.77M
22.41B
(IOVA) Total Revenue
(ET) Total Revenue
Values in USD except per share items